×
Entrez Id: 145864
Gene Symbol: HAPLN3
HAPLN3
0.100
GeneticVariation
disease
GWASCAT
A genome-wide association study identifies single nucleotide polymorphisms associated with time-to-metastasis in colorectal cancer.
30738427 2019
×
Entrez Id: 118788
Gene Symbol: PIK3AP1
PIK3AP1
0.100
GeneticVariation
disease
GWASCAT
A genome-wide association study identifies single nucleotide polymorphisms associated with time-to-metastasis in colorectal cancer.
30738427 2019
×
Entrez Id: 339479
Gene Symbol: BRINP3
BRINP3
0.100
GeneticVariation
disease
GWASCAT
A genome-wide association study identifies single nucleotide polymorphisms associated with time-to-metastasis in colorectal cancer.
30738427 2019
×
Entrez Id: 11320
Gene Symbol: MGAT4A
MGAT4A
0.100
GeneticVariation
disease
GWASCAT
Genome Wide Association Study for Predictors of Progression Free Survival in Patients on Capecitabine, Oxaliplatin, Bevacizumab and Cetuximab in First-Line Therapy of Metastatic Colorectal Cancer.
26222057 2015
MIR7515HG
0.100
GeneticVariation
disease
GWASCAT
A genome-wide association study identifies single nucleotide polymorphisms associated with time-to-metastasis in colorectal cancer.
30738427 2019
×
Entrez Id: 27241
Gene Symbol: BBS9
BBS9
0.100
GeneticVariation
disease
GWASCAT
A genome-wide association study identifies single nucleotide polymorphisms associated with time-to-metastasis in colorectal cancer.
30738427 2019
×
Entrez Id: 7528
Gene Symbol: YY1
YY1
0.100
GeneticVariation
disease
GWASCAT
A genome-wide association study identifies single nucleotide polymorphisms associated with time-to-metastasis in colorectal cancer.
30738427 2019
×
Entrez Id: 84913
Gene Symbol: ATOH8
ATOH8
0.100
GeneticVariation
disease
GWASCAT
A genome-wide association study identifies single nucleotide polymorphisms associated with time-to-metastasis in colorectal cancer.
30738427 2019
×
Entrez Id: 5430
Gene Symbol: POLR2A
POLR2A
0.100
GeneticVariation
disease
GWASCAT
A genome-wide association study identifies single nucleotide polymorphisms associated with time-to-metastasis in colorectal cancer.
30738427 2019
×
Entrez Id: 6014
Gene Symbol: RIT2
RIT2
0.100
GeneticVariation
disease
GWASCAT
A genome-wide association study identifies single nucleotide polymorphisms associated with time-to-metastasis in colorectal cancer.
30738427 2019
×
Entrez Id: 23245
Gene Symbol: ASTN2
ASTN2
0.100
GeneticVariation
disease
GWASCAT
A genome-wide association study identifies single nucleotide polymorphisms associated with time-to-metastasis in colorectal cancer.
30738427 2019
×
Entrez Id: 2047
Gene Symbol: EPHB1
EPHB1
0.100
GeneticVariation
disease
GWASCAT
A genome-wide association study identifies single nucleotide polymorphisms associated with time-to-metastasis in colorectal cancer.
30738427 2019
×
Entrez Id: 2272
Gene Symbol: FHIT
FHIT
0.100
GeneticVariation
disease
GWASCAT
A genome-wide association study identifies single nucleotide polymorphisms associated with time-to-metastasis in colorectal cancer.
30738427 2019
×
Entrez Id: 152579
Gene Symbol: SCFD2
SCFD2
0.100
GeneticVariation
disease
GWASCAT
A genome-wide association study identifies single nucleotide polymorphisms associated with time-to-metastasis in colorectal cancer.
30738427 2019
×
Entrez Id: 6444
Gene Symbol: SGCD
SGCD
0.100
GeneticVariation
disease
GWASCAT
A genome-wide association study identifies single nucleotide polymorphisms associated with time-to-metastasis in colorectal cancer.
30738427 2019
×
Entrez Id: 140733
Gene Symbol: MACROD2
MACROD2
0.100
GeneticVariation
disease
GWASCAT
A genome-wide association study identifies single nucleotide polymorphisms associated with time-to-metastasis in colorectal cancer.
30738427 2019
×
Entrez Id: 146713
Gene Symbol: RBFOX3
RBFOX3
0.100
GeneticVariation
disease
GWASCAT
A genome-wide association study identifies single nucleotide polymorphisms associated with time-to-metastasis in colorectal cancer.
30738427 2019
×
Entrez Id: 1956
Gene Symbol: EGFR
EGFR
0.100
Biomarker
disease
BEFREE
The prognostic role of BRAF mutation in metastatic colorectal cancer receiving anti-EGFR monoclonal antibodies: a meta-analysis.
23776587 2013
×
Entrez Id: 1956
Gene Symbol: EGFR
EGFR
0.100
Biomarker
disease
BEFREE
Second-line treatment with chemotherapy and anti-epidermal growth factor receptor or anti-vascular endothelial growth factor antibodies improves outcomes in patients with wild type Kirsten rat sarcoma viral oncogene homolog (KRAS) metastatic colorectal cancer (mCRC ).
25982297 2015
×
Entrez Id: 3845
Gene Symbol: KRAS
KRAS
0.100
Biomarker
disease
BEFREE
20 patients with wild-type KRAS mCRC were included in this phase I/II study.
23504398 2013
×
Entrez Id: 1956
Gene Symbol: EGFR
EGFR
0.100
Biomarker
disease
BEFREE
Previous studies indicate that drugs targeting the Epidermal Growth Factor Receptor (EGFR) signaling pathways can induce objective responses, prolong time to progression and improve survival of patients with metastatic colorectal cancer (mCRC ).
20595818 2010
×
Entrez Id: 79947
Gene Symbol: DHDDS
DHDDS
0.100
GeneticVariation
disease
BEFREE
A phase I study of UGT1A1 *28/*6 genotype-directed dosing of irinotecan (CPT -11) in Korean patients with metastatic colorectal cancer receiving FOLFIRI.
25427841 2015
×
Entrez Id: 1956
Gene Symbol: EGFR
EGFR
0.100
Biomarker
disease
BEFREE
KRAS mutation testing before anti-epidermal growth factor receptor therapy of metastatic colorectal cancer has become mandatory in Europe.
20007841 2010
×
Entrez Id: 2212
Gene Symbol: FCGR2A
FCGR2A
0.100
Biomarker
disease
BEFREE
The FcγRIIa and FcγRIIIa polymorphisms may not be useful molecular biomarkers for the activity of cetuximab in patients with mCRC .
22327884 2012
×
Entrez Id: 3845
Gene Symbol: KRAS
KRAS
0.100
Biomarker
disease
BEFREE
The standard of care for mCRC has evolved to incorporate cytotoxic chemotherapy as the backbone regimens (eg, FOLFOX [folinic acid, 5-fluorouracil, and oxaliplatin], FOLFIRI [folinic acid, 5-fluorouracil, and irinotecan]) with or without bevacizumab, and epidermal growth factor receptor-targeted therapies (eg, cetuximab, panitumumab) in the setting of wild-type KRAS .
24768040 2014